Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shefali Khanna Sharma

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
The Journal of the Association of Physicians of India|August 25, 2017
Use of Biologics and Biosimilars in RheumatologyShefali Khanna Sharma
Journal of Thoracic Disease|August 9, 2016
The role of danger-associated molecular patterns (DAMPs) in trauma and infectionsShefali Khanna Sharma, Gsrsnk Naidu
International Journal of Rheumatic Diseases|February 13, 2018
Chikungunya: A rheumatologist's perspectiveShefali Khanna Sharma, Sanjay Jain
Annals of the Rheumatic Diseases|August 2, 2020
Rational use of tocilizumab in COVID-19Siddharth Jain, Shefali Khanna Sharma
Annals of the Rheumatic Diseases|May 24, 2019
Differentiating disease activity from damage in systemic sclerosis: it's still early days!Siddharth Jain, Shefali Khanna Sharma
International Journal of Rheumatic Diseases|June 19, 2026
Lung Adenocarcinoma in Systemic Sclerosis-Associated Interstitial Lung Disease: A Novel Insight, Anjali Meena, Ritambhra Nada, et al.
The Lancet. Rheumatology|September 23, 2020
Tocilizumab in COVID-19: finding the optimal route and doseSiddharth Jain, Sanjay Jain, Shefali Khanna Sharma
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|June 6, 2019
Calcinosis Cutis at an Unusual LocationArghya Chattopadhyay, Debashish Mishra, Shefali Khanna Sharma
International Journal of Rheumatic Diseases|July 25, 2017
A randomized controlled trial to study the efficacy of sulfasalazine for axial disease in ankylosing spondylitisShefali Khanna Sharma, Vikas Kadiyala, Gsrsnk Naidu, et al.
Clinical Rheumatology|February 11, 2016
Can thyroid volume predict thyroid dysfunction in patients with systemic sclerosis? A prospective cross-sectional study from a tertiary care center in North West IndiaPawan Kumar Singh, Shefali Khanna Sharma, Anindita Sinha, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
The Journal of the Association of Physicians of India|August 25, 2017
Use of Biologics and Biosimilars in RheumatologyShefali Khanna Sharma
Journal of Thoracic Disease|August 9, 2016
The role of danger-associated molecular patterns (DAMPs) in trauma and infectionsShefali Khanna Sharma, Gsrsnk Naidu
International Journal of Rheumatic Diseases|February 13, 2018
Chikungunya: A rheumatologist's perspectiveShefali Khanna Sharma, Sanjay Jain
Annals of the Rheumatic Diseases|August 2, 2020
Rational use of tocilizumab in COVID-19Siddharth Jain, Shefali Khanna Sharma
Annals of the Rheumatic Diseases|May 24, 2019
Differentiating disease activity from damage in systemic sclerosis: it's still early days!Siddharth Jain, Shefali Khanna Sharma
International Journal of Rheumatic Diseases|June 19, 2026
Lung Adenocarcinoma in Systemic Sclerosis-Associated Interstitial Lung Disease: A Novel Insight, Anjali Meena, Ritambhra Nada, et al.
The Lancet. Rheumatology|September 23, 2020
Tocilizumab in COVID-19: finding the optimal route and doseSiddharth Jain, Sanjay Jain, Shefali Khanna Sharma
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|June 6, 2019
Calcinosis Cutis at an Unusual LocationArghya Chattopadhyay, Debashish Mishra, Shefali Khanna Sharma
International Journal of Rheumatic Diseases|July 25, 2017
A randomized controlled trial to study the efficacy of sulfasalazine for axial disease in ankylosing spondylitisShefali Khanna Sharma, Vikas Kadiyala, Gsrsnk Naidu, et al.
Clinical Rheumatology|February 11, 2016
Can thyroid volume predict thyroid dysfunction in patients with systemic sclerosis? A prospective cross-sectional study from a tertiary care center in North West IndiaPawan Kumar Singh, Shefali Khanna Sharma, Anindita Sinha, et al.
Pageof 3